Brokerages Set Inozyme Pharma, Inc. (NASDAQ:INZY) Target Price at $14.56
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]
